Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

allogeneic AdV/CMV/EBV-specific T lymphocytes

A preparation of human leukocyte antigen (HLA)-matched or HLA-mismatched, allogeneic CD4+ and CD8+ T lymphocytes, ex vivo incubated with synthetic peptides of the viral antigens of the three human viruses adenovirus (AdV), cytomegalovirus (CMV) and Epstein-Barr virus (EBV), with potential antiviral activity. Upon administration of the allogeneic AdV/CMV/EBV-specific T lymphocytes after allogeneic hematopoietic stem cell transplantation (HSCT), these T lymphocytes may kill AdV, CMV, and/or EBV-infected cells, and may prevent or reduce the severity of viral infections by these pathogens.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:allogeneic AdV/CMV/EBV multi-virus-specific T lymphocytes
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search